169 related articles for article (PubMed ID: 34157979)
1. Therapeutic prediction of HIV-1 DNA decay: a multicenter longitudinal cohort study.
Yue Y; Li Y; Cui Y; Wang N; Huang Y; Cao W; Han Y; Zhu T; Lyu W; Xie J; Song X; Li Y; Wang T; Zhu T; Li T
BMC Infect Dis; 2021 Jun; 21(1):592. PubMed ID: 34157979
[TBL] [Abstract][Full Text] [Related]
2. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study.
Lyu T; Yue Y; Hsieh E; Han Y; Zhu T; Song X; Cao W; Lyu W; Wang J; Li T
BMC Infect Dis; 2020 Jan; 20(1):66. PubMed ID: 31964364
[TBL] [Abstract][Full Text] [Related]
4. The effects of antiretroviral therapy initiation time on HIV reservoir size in Chinese chronically HIV infected patients: a prospective, multi-site cohort study.
Luo L; Wang N; Yue Y; Han Y; Lv W; Liu Z; Qiu Z; Lu H; Tang X; Zhang T; Zhao M; He Y; Shenghua H; Wang M; Li Y; Huang S; Li Y; Liu J; Tuofu Z; Routy JP; Li T
BMC Infect Dis; 2019 Mar; 19(1):257. PubMed ID: 30871484
[TBL] [Abstract][Full Text] [Related]
5. A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control.
Assoumou L; Weiss L; Piketty C; Burgard M; Melard A; Girard PM; Rouzioux C; Costagliola D;
AIDS; 2015 Sep; 29(15):2003-7. PubMed ID: 26355572
[TBL] [Abstract][Full Text] [Related]
6. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
Uprety P; Chadwick EG; Rainwater-Lovett K; Ziemniak C; Luzuriaga K; Capparelli EV; Yenokyan G; Persaud D
Clin Infect Dis; 2015 Dec; 61(12):1862-70. PubMed ID: 26270687
[TBL] [Abstract][Full Text] [Related]
7. Extremely low viral reservoir in treated chronically HIV-1-infected individuals.
Gálvez C; Urrea V; Dalmau J; Jimenez M; Clotet B; Monceaux V; Huot N; Leal L; González-Soler V; González-Cao M; Müller-Trutwin M; Sáez-Cirión A; García F; Blanco J; Martinez-Picado J; Salgado M
EBioMedicine; 2020 Jul; 57():102830. PubMed ID: 32580136
[TBL] [Abstract][Full Text] [Related]
8. Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection.
Uprety P; Patel K; Karalius B; Ziemniak C; Chen YH; Brummel SS; Siminski S; Van Dyke RB; Seage GR; Persaud D;
Clin Infect Dis; 2017 Jun; 64(11):1471-1478. PubMed ID: 28329153
[TBL] [Abstract][Full Text] [Related]
9. Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success.
Alteri C; Scutari R; Stingone C; Maffongelli G; Brugneti M; Falasca F; Martini S; Bertoli A; Turriziani O; Sarmati L; Coppola N; Andreoni M; Santoro MM; Perno CF; Ceccherini-Silberstein F; Svicher V
J Clin Virol; 2019 Aug; 117():61-67. PubMed ID: 31229934
[TBL] [Abstract][Full Text] [Related]
10. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level.
Viard JP; Burgard M; Hubert JB; Aaron L; Rabian C; Pertuiset N; Lourenço M; Rothschild C; Rouzioux C
AIDS; 2004 Jan; 18(1):45-9. PubMed ID: 15090828
[TBL] [Abstract][Full Text] [Related]
11. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
12. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
[TBL] [Abstract][Full Text] [Related]
13. Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial.
Achenbach CJ; Assoumou L; Deeks SG; Wilkin TJ; Berzins B; Casazza JP; Lambert-Niclot S; Koup RA; Costagliola D; Calvez V; Katlama C; Autran B; Murphy RL;
Lancet HIV; 2015 Mar; 2(3):e82-91. PubMed ID: 26424549
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adults.
Minga AK; Anglaret X; d' Aquin Toni T; Chaix ML; Dohoun L; Abo Y; Coulibaly A; Duvignac J; Gabillard D; Rouet F; Rouzioux C
J Acquir Immune Defic Syndr; 2008 Jul; 48(3):350-4. PubMed ID: 18545149
[TBL] [Abstract][Full Text] [Related]
15. Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants.
McManus M; Mick E; Hudson R; Mofenson LM; Sullivan JL; Somasundaran M; Luzuriaga K;
PLoS One; 2016; 11(4):e0154391. PubMed ID: 27104621
[TBL] [Abstract][Full Text] [Related]
16. Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA.
Laanani M; Ghosn J; Essat A; Melard A; Seng R; Gousset M; Panjo H; Mortier E; Girard PM; Goujard C; Meyer L; Rouzioux C;
Clin Infect Dis; 2015 Jun; 60(11):1715-21. PubMed ID: 25737374
[TBL] [Abstract][Full Text] [Related]
17. HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients.
Golob JL; Stern J; Holte S; Kitahata MM; Crane HM; Coombs RW; Goecker E; Woolfrey AE; Harrington RD
AIDS; 2018 Sep; 32(15):2113-2118. PubMed ID: 30005008
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
[TBL] [Abstract][Full Text] [Related]
19. Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir.
Calin R; Hamimi C; Lambert-Niclot S; Carcelain G; Bellet J; Assoumou L; Tubiana R; Calvez V; Dudoit Y; Costagliola D; Autran B; Katlama C;
AIDS; 2016 Mar; 30(5):761-9. PubMed ID: 26730568
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.
Besson GJ; Lalama CM; Bosch RJ; Gandhi RT; Bedison MA; Aga E; Riddler SA; McMahon DK; Hong F; Mellors JW
Clin Infect Dis; 2014 Nov; 59(9):1312-21. PubMed ID: 25073894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
